Avandia
18 Nov 2008 10:51:20
APPROACH fails to find atherosclerosis benefit for Avandia - Scrip World Pharmaceutical News (subscription)
APPROACH fails to find atherosclerosis benefit for Avandia Scrip World Pharmaceutical News (subscription), UK - GlaxoSmithKline's diabetes therapy Avandia (rosiglitazone) has failed to show any benefit on atherosclerosis progression when compared with the older ...
17 Nov 2008 20:58:04
Source: FDA to Require Meta Analyses of Diabetes Drug Studies - BNET
Source: FDA to Require Meta Analyses of Diabetes Drug Studies BNET, Ca - At that meeting, Steve Nissen of the Cleveland Clinic Foundation (and the curse of Avandia ) urged tighter standards for CV events before new diabetes drugs ...
17 Nov 2008 16:37:28
Merck launches long-term Januvia trial - FiercePharma
Merck launches long-term Januvia trial FiercePharma, DC - Think Zyprexa, the Eli Lilly antipsychotic that's been shown to boost the risk of weight gain and diabetes, or Avandia , the GlaxoSmithKline diabetes drug ...
17 Nov 2008 02:51:13
Consumer Group Wants Ban on Avandia - InjuryBoard.com
Consumer Group Wants Ban on Avandia InjuryBoard.com, FL - Public Citizen, a consumer group, wants the diabetes drug Avandia banned from the market. The group recently petitioned the FDA for the ban on the basis ...
12 Nov 2008 19:40:17
Is Avandia All It's Plaqued Up To Be? - Forbes
Is Avandia All It's Plaqued Up To Be? Forbes, NY - GlaxoSmithKline says a new study shows controversial diabetes drug Avandia may clear heart attack-causing plaque out of the arteries. ... UPDATE 1-Glaxo's Avandia fails to slow plaque progression Avandia Disappoints Again, Doesnt Significantly Reduce Arterial ... 'Neutral' study isn't good enough for Avandia -
07 Nov 2008 14:06:36
Safety Concerns about Diabetes Drug Avandia - InjuryBoard.com
Safety Concerns about Diabetes Drug Avandia InjuryBoard.com, FL - Avandia is a popular type 2 diabetes drug that was first marketed in 1999. It is one of many oral medications designed to control blood sugar. ... Avandia Too Toxic to Be On The Market
30 Oct 2008 20:19:14
Consumer Group Seeks FDA Ban on Avandia - U.S. News & World Report
SmartAboutHealth Consumer Group Seeks FDA Ban on Avandia U.S. News & World Report, DC - THURSDAY, Oct. 30 (HealthDay News) -- The diabetes drug Avandia should be banned in the United States because it can cause death from liver failure and ... Consumer Group Seeks FDA Ban of Glaxo's Avandia Public Citizen wants GSK's Avandia off the market UPDATE 2-Liver risk, death seen with Glaxo's Avandia -group -27 Oct 2008 23:04:08
Do Diabetes Drugs Affect Heart Health? - WebMD
24 Oct 2008 17:53:40
Avandia Heart Risks Cause Diabetes Associations to Recommend ... - AboutLawsuits.com
RTT News Avandia Heart Risks Cause Diabetes Associations to Recommend ... AboutLawsuits.com - As a result of serious concerns about the side effects of Avandia , which include an increased risk of heart attacks, congestive heart failure and other ... GlaxoSmithKline eyes further acquisitions Glaxo to Competitors: You're Cheaper Than We Are GSK will look at buying biotech firms in credit crunch -22 Oct 2008 17:31:04
New Europe, US diabetes guidelines drop Avandia - Reuters
New Europe, US diabetes guidelines drop Avandia Reuters - Sales of Avandia have plummeted in the past year after the drug was linked to risk of heart attack in a pooled analysis of past clinical studies. ... Guidelines Drop Rosiglitazone as Recommend Diabetes Agent Treatment for Type 2 Diabetes Updated American Diabetes Association, European Association for the Study ...
Avandia
